Initiated Hold X

SLP Simulations Plus

TD Cowen

$16

Downgrades Overweight Sec Weight X

SLP Simulations Plus

KeyBanc Capital Markets

Initiated Overweight X

SLP Simulations Plus

Stephens

$39

Initiated Overweight X

SLP Simulations Plus

KeyBanc Capital Markets

$47

Initiated Mkt Perform X

SLP Simulations Plus

JMP Securities

Initiated Outperform X

SLP Simulations Plus

William Blair

Initiated Buy X

SLP Simulations Plus

BTIG Research

$55

Upgrades Hold Buy X

SLP Simulations Plus

Craig Hallum

$65 $53

Downgrades Buy Hold X

SLP Simulations Plus

Craig Hallum

SLP  Simulations Plus, Inc.

Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.